Trusted Resource for Clinical Trials, Protocols & Progress
In 2023, a mid-sized European sponsor initiated a Phase III decentralized clinical trial (DCT) for a dermatological therapy involving 1,800 patients across 6 countries. The study utilized wearable skin imaging devices, home-based ePRO (electronic Patient-Reported Outcomes), and a cloud-hosted CTMS to manage operations.
Click to read the full article.
Quantum computing is no longer a theoretical concept. With breakthroughs in quantum processors and qubit stability, the possibility of breaking traditional encryption schemes like RSA-2048 and ECC is looming on the horizon. Clinical trial data, rich in personal health information (PHI), proprietary formulations, and intellectual property, is a prime target.
Click to read the full article.
Traditional encryption mechanisms—while foundational to digital data security—face growing limitations in the context of modern, multi-regional clinical trials. The rise of decentralized studies, wearable sensors, and remote monitoring technologies has introduced new data flows that legacy encryption strategies struggle to handle.
Click to read the full article.
Encryption protects sensitive data in clinical trials, but the real strength lies in how encryption keys are managed. Mismanaged keys can render even the strongest encryption ineffective. Regulatory bodies such as the FDA, EMA, and HIPAA all require not just encryption—but robust, validated key management strategies.
Click to read the full article.
Wearables have transformed clinical trials by enabling real-time monitoring of physiological parameters such as heart rate, sleep patterns, glucose levels, and activity data. From wrist-worn devices to patches and smart garments, these sensors generate vast amounts of electronic source (eSource) data that flow continuously across wireless channels.
Click to read the full article.
Clinical Trial Management Systems (CTMS) are increasingly hosted on cloud infrastructures due to their scalability, remote accessibility, and cost-effectiveness. However, this convenience comes with increased responsibility for securing sensitive trial data, including Protected Health Information (PHI), investigator records, site contracts, and payment histories.
Click to read the full article.
Protected Health Information (PHI) includes any individually identifiable health data collected during clinical trials, such as patient names, medical record numbers, lab results, and treatment history. The Health Insurance Portability and Accountability Act (HIPAA) mandates administrative, technical, and physical safeguards to ensure PHI confidentiality and integrity.
Click to read the full article.
In Electronic Data Capture (EDC) systems, sensitive patient data flows from investigator sites to CROs and sponsors, often via the internet or cloud-based systems. End-to-End Encryption (E2EE) ensures that this data remains confidential and tamper-proof from source to destination.
Click to read the full article.
Clinical trial systems handle sensitive information, including patient health data, investigational product data, protocol deviations, and audit logs. Ensuring this information is protected from unauthorized access or manipulation is a GCP and HIPAA requirement.
Click to read the full article.
